chr5-35072610-T-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000949.7(PRLR):​c.508A>C​(p.Ile170Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0238 in 1,614,040 control chromosomes in the GnomAD database, including 539 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.018 ( 40 hom., cov: 32)
Exomes 𝑓: 0.024 ( 499 hom. )

Consequence

PRLR
NM_000949.7 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity no assertion criteria provided P:1B:2

Conservation

PhyloP100: 0.156

Publications

37 publications found
Variant links:
Genes affected
PRLR (HGNC:9446): (prolactin receptor) This gene encodes a receptor for the anterior pituitary hormone, prolactin, and belongs to the type I cytokine receptor family. Prolactin-dependent signaling occurs as the result of ligand-induced dimerization of the prolactin receptor. Several alternatively spliced transcript variants encoding different membrane-bound and soluble isoforms have been described for this gene, which may function to modulate the endocrine and autocrine effects of prolactin in normal tissue and cancer. [provided by RefSeq, Feb 2011]
PRLR Gene-Disease associations (from GenCC):
  • familial hyperprolactinemia
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005667001).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0184 (2803/152282) while in subpopulation NFE AF = 0.0257 (1750/68006). AF 95% confidence interval is 0.0247. There are 40 homozygotes in GnomAd4. There are 1326 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 2803 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRLRNM_000949.7 linkc.508A>C p.Ile170Leu missense_variant Exon 6 of 10 ENST00000618457.5 NP_000940.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRLRENST00000618457.5 linkc.508A>C p.Ile170Leu missense_variant Exon 6 of 10 1 NM_000949.7 ENSP00000482954.1

Frequencies

GnomAD3 genomes
AF:
0.0184
AC:
2800
AN:
152164
Hom.:
40
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0235
Gnomad ASJ
AF:
0.0153
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00580
Gnomad FIN
AF:
0.0214
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0257
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0188
AC:
4724
AN:
251230
AF XY:
0.0186
show subpopulations
Gnomad AFR exome
AF:
0.00775
Gnomad AMR exome
AF:
0.0137
Gnomad ASJ exome
AF:
0.0225
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0233
Gnomad NFE exome
AF:
0.0272
Gnomad OTH exome
AF:
0.0206
GnomAD4 exome
AF:
0.0244
AC:
35608
AN:
1461758
Hom.:
499
Cov.:
31
AF XY:
0.0239
AC XY:
17397
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.00848
AC:
284
AN:
33474
American (AMR)
AF:
0.0153
AC:
683
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0203
AC:
530
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00539
AC:
465
AN:
86232
European-Finnish (FIN)
AF:
0.0240
AC:
1281
AN:
53420
Middle Eastern (MID)
AF:
0.0258
AC:
149
AN:
5768
European-Non Finnish (NFE)
AF:
0.0278
AC:
30873
AN:
1111940
Other (OTH)
AF:
0.0222
AC:
1343
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1838
3676
5513
7351
9189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1186
2372
3558
4744
5930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0184
AC:
2803
AN:
152282
Hom.:
40
Cov.:
32
AF XY:
0.0178
AC XY:
1326
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00799
AC:
332
AN:
41564
American (AMR)
AF:
0.0235
AC:
359
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
53
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.00622
AC:
30
AN:
4826
European-Finnish (FIN)
AF:
0.0214
AC:
227
AN:
10612
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0257
AC:
1750
AN:
68006
Other (OTH)
AF:
0.0194
AC:
41
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
142
284
427
569
711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0235
Hom.:
141
Bravo
AF:
0.0180
TwinsUK
AF:
0.0316
AC:
117
ALSPAC
AF:
0.0231
AC:
89
ESP6500AA
AF:
0.00749
AC:
33
ESP6500EA
AF:
0.0240
AC:
206
ExAC
AF:
0.0190
AC:
2305
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0268
EpiControl
AF:
0.0258

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:2
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Multiple fibroadenoma of the breast Pathogenic:1Benign:1
Nov 21, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

NM_000949.5:c.508A>C (Ile170Leu) was reported as I146L in the literature. Bogorad et al. used multiple functional assays, which unambiguously converge to the evidence that I146L exhibits constitutive activity, highlighting the remarkable effect of this single substitution on the biological properties of the PrlR (PMID: 24195502). This variant has an allele frequency of 0.027 in European (non-Finnish) subpopulation in the gnomAD database, including 71 homozygous occurrences. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, PS3. -

PRLR-related disorder Benign:1
Jul 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
7.5
DANN
Benign
0.58
DEOGEN2
Benign
0.17
.;.;.;.;.;.;.;T;.;.;.
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.70
.;.;T;T;T;.;T;T;.;.;T
MetaRNN
Benign
0.0057
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.35
N;N;N;N;N;N;.;N;.;N;N
PhyloP100
0.16
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.010
N;N;.;N;.;N;.;.;N;N;.
REVEL
Benign
0.044
Sift
Benign
1.0
T;T;.;T;.;T;.;.;T;T;.
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;B;B;B;B;B;B;B;B;.;.
Vest4
0.16
ClinPred
0.0017
T
GERP RS
-1.0
Varity_R
0.12
gMVP
0.57
Mutation Taster
=98/2
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72478580; hg19: chr5-35072712; COSMIC: COSV107223452; API